← Eichor
Study identifier: NCT05929755 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Depo-Medrol on Psoas After LLIF

Condition: Muscle Weakness · Pain, Postoperative · Paresthesia  ·  Sponsor: Hardeep Singh

PhasePhase 4
Planned participants80
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The goal of this study is to determine the effects of a corticosteroid administered to the psoas muscle following a transpsoas lateral lumbar interbody fusion (LLIF) on postoperative hip flexor weakness and thigh pain and numbness.

This description comes directly from the study's public registry record.

Talk to the study team

Hardeep Singh, MD  ·  860-679-6883  ·  uconnorthopaedics@uchc.edu

Study Coordinator  ·  860-679-6883  ·  uconnorthopaedics@uchc.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UConn HealthFarmington, Connecticut, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05929755